关于我们ABOUT US
关于我们
ABOUT US
水木未来（北京）科技有限公司是一家结构和AI计算驱动的新型药物研发平台型公司，建立了亚太第一个300kV冷冻电镜商业化服务平台，基于结构生物学、深度学习和高性能计算核心技术，在小分子、抗体药、蛋白降解、基因治疗等领域推动药物研发的数字化创新，助力全球创新药企大幅提升药物研发效率和成功率。已成功为来自中国、美国、欧洲的50余家创新药企和顶级科研机构提供了结构生物学和药物发现服务。
Tomo BioSciences Ltd. (TomoBio) is a Cryo-EM and AI driven drug discovery platform. Founded in 2017 at Tsinghua University with a core team of outstanding life and computational scientists, AI and pharmaceutical industry experts, TomoBio has successfully provided structural biology and drug discovery services to more than 50 innovative pharmaceutical companies and top research institutions from China, the United States and Europe since its inception.
